Detecting drug-induced toxicity involves monitoring for signs and symptoms of adverse effects. Clinical assessments, including routine blood tests, can help identify organ dysfunction before severe damage occurs. Biomarkers, which are measurable indicators of a biological condition, are increasingly used to detect early signs of toxicity, especially in organs like the liver and kidneys. Furthermore, patient-reported outcomes can provide valuable insights into adverse effects that may not be immediately evident through clinical tests.
